It is imperative that clinicians understand the differences in each patient and how effective therapies must be individualized and often combined to treat patients with varying profiles. Efforts to unify heart failure across the ejection fraction and rebrand "heart failure" to "heart success" may be achieved by better understanding patients to prevent progression to stage C or D.

In this episode, Dr. Jim Januzzi interviews guideline author Dr. Lynne Stevenson on the importance of understanding the optimal evaluation and management of patients with heart failure.

This podcast is part of the Heart Failure & SGLT2is: The New Pillar in Care grant initiative.

In this interview, Vidhu Anand, MD, FACC, and Alison L. Bailey, MD, FACC, provide a comprehensive exploration of Low Flow-Low Gradient Aortic Stenosis, shedding light on its definition and exploring treatment approaches for patients with HF.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

With EMPACT-MI being presented at ACC, the definitive study of an additional agent (empagliflozin) will allow for a great discussion on options for patients who have acute MI and evidence of heart failure.

In this interview, Schuyler Jones, MD FACC, and Purvi Parwani, MBBS, MPH, FACC discuss Not the Same Old 5 Medications: Contemporary GDMT Algorithm in the Post-MI Patient.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

High levels of Lp(a) impact approximately 1 in 5 individuals globally, signaling an elevated risk of heart attacks, strokes, and valve disease. How should clinicians navigate this challenge, given the current lack of specific treatment options?

In this interview, Raul Santos MD, PhD, and Sun Moon Kim MD, FACC discuss strategies to lowering an elevated Lp(a) based on current evidence and available treatments.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Understanding the etiology of left ventricular hypertrophy is increasingly important due to the increasing number of targeted therapies coming online. This discussion provides a high-level approach to differentiating important causes of increased wall thickness.

In this interview, Timothy C. Wong, MD, MS, FACC and Sidney C. Smith Jr., MD, MACC discuss pitfalls in the diagnosis of HCM.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL

Incorporating spiritual evaluation into medical science is worth consideration. The presence of edifying emotions can potentially yield positive effects on hypertension treatment outcomes.

In this interview, Maria Emília Figueiredo Teixeira, MD, PhD and Sidney C. Smith Jr., MD, MACC discuss the primary findings uncovered by the Feel Trial.

Subscribe on Apple Podcasts | Subscribe on Google Play | Subscribe to ACCEL